New York City (NYC) has become the epicenter of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). By collecting and summarizing the experience with other major health care providers in the tristate (New York (NY), New Jersey (NJ) and Connecticut (CT)) are, the investigators are uniquely positioned to inform the rest of the country about what to expect and how to manage children and young adults with hematological, oncological or stem cell transplant diagnoses during the pandemic.
The subjects are all pediatric hematology, oncology or stem cell transplant (HOT) children
and young adults who are tested for SARS-CoV-2. The investigators will collect data including
demographics, clinical characteristics, clinical courses, outcomes from the medical record.
Other information about finances, mental health, and nutrition will be ascertained by
questionnaires. The subjects will be asked to allow the researchers to abstract information
from their medical record, participate in an interview or telephone call (their choice) to
answer questionnaires, and to provide a stool sample at three time points.
The creation of an integrated database of COVID-19 pediatric and young adult patients will
better inform the pediatric hematology, oncology, and stem cell transplant community about
this disease specifically related to patients undergoing HOT therapy and provide valuable
evidence to develop standardized and clinically appropriate approaches to their care.
Inclusion Criteria:
- Hematologic, Oncologic or Stem Cell Transplant Diagnosis
- Tested for COVID-19
- Age up to 21 years of age
Exclusion Criteria:
- Unwillingness to participate
Columbia University Irving Medical Center
New York, New York, United States
Prakash Satwani, MD, Principal Investigator
Columbia University